5don MSN
A research team led by Rice University's Yang Gao has uncovered new insights into the molecular mechanisms of ADAR1, a ...
The research field of 'cellular IRESes' lay dormant for decades, as there was no uniform standard of reliable methods for the clear characterization of these starting points for the ribosome-mediated ...
5d
Interesting Engineering on MSNScientists unravel RNA-editing mystery, paving way for next-gen cancer treatmentsScientists have made a major discovery about ADAR1—a protein that controls RNA-induced immune responses—paving ...
In addition to exporting materials out of the nucleus, the protein, called Exportin-1 (also called Xpo1 or Crm1), seems to play a role in promoting gene transcription, the process that creates RNA ...
Researchers uncover new insights into the molecular mechanisms of ADAR1, a protein that regulates RNA-induced immune responses. Their findings could open new pathways for treating autoimmune diseases ...
For the Liu Lab, necessity is truly the mother of invention. The researchers were examining how the 3D organization of the ...
Genes have to be expressed in the right place, at the time, and at the right levels. Scientists wanted to know more about how ...
5don MSN
This tool uses the multifunctionality of the natural RNA biomolecule to fold new building blocks, making protein synthesis ...
Similarly, cells splice RNA in different ways to produce a variety of proteins from a single gene, fine-tuning their function based on need. However, when cancer rewrites the script, this process goes ...
A study reveals how cancer disrupts RNA splicing and presents a potential therapy using antisense oligonucleotides to target ...
2d
News Medical on MSNStarting points for the control of protein synthesis / Bonn researchers develop a versatile toolbox for the characterization of IRESes in cellsThe research field of "cellular IRESes" lay dormant for decades, as there was no uniform standard of reliable methods for the ...
The report delivers a comprehensive analysis of global biologics sales. Covering cancer antibodies, non-TNF inflammatory mAbs, biosimilars, gene therapy, RNA-based drugs, and more, the report provides ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results